However, it is noteworthy that the presence of H. pylori and EGF/HER2 activation, which up-regulates PD-L1/PD-L2 expression and downregulating DNA repair machinery, has contributed to the identification of more specific GC subsets that are potentially responsive to combination of chemo-immunotherapies. This evidence concerns the gene PDCD1LG2 and gastric cancer.